Monthly Archives: August 2025

Younger men have higher risk for mortality and cardiovascular disease for type 2 diabetes

26th August 2025

You can sign in with OneKey / OWA to view this content.

Read more

Discontinuation of Levemir® (insulin detemir)

22nd August 2025

You can sign in with OneKey / OWA to view this content.

Read more

Diabetes technology and HCL scoping document to be launched

22nd August 2025

You can sign in with OneKey / OWA to view this content.

Read more

SGLT-2 inhibitors to become first-choice treatments for type 2 diabetes

20th August 2025

You can sign in with OneKey / OWA to view this content.

Read more

Teplizumab authorised by the MHRA

15th August 2025

You can sign in with OneKey / OWA to view this content.

Read more

Mounjaro demonstrated cardiovascular protection in landmark trial

14th August 2025

You can sign in with OneKey / OWA to view this content.

Read more